OR WAIT null SECS
Vice President, Vetter Development Service, Vetter Pharma-Fertigung GmbH & Co. KG
Partnering with CDMOs can help bridge the innovation gap.
Biotechnology projects are complex and subject to many levels of risk during the early clinical phases. What are the secrets to winning at the drug development game?